Table of Content
Introduction
Muscular Dystrophy- Overview
Muscular Dystrophy- Therapeutics Development
Muscular Dystrophy- Therapeutics Assessment
Muscular Dystrophy- Companies Involved in Therapeutics Development
Muscular Dystrophy- Drug Profiles
Muscular Dystrophy- Dormant Projects
Muscular Dystrophy- Discontinued Products
Muscular Dystrophy- Product Development Milestones
Appendix
List of Figures
Number of Products under Development for Muscular Dystrophy, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020
List of Tables
Number of Products under Development for Muscular Dystrophy, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Muscular Dystrophy - Pipeline by Achelios Therapeutics Inc, H2 2020
Muscular Dystrophy - Pipeline by AlloMek Therapeutics, H2 2020
Muscular Dystrophy - Pipeline by Amicus Therapeutics Inc, H2 2020
Muscular Dystrophy - Pipeline by AMO Pharma Ltd, H2 2020
Muscular Dystrophy - Pipeline by Anima Biotech Inc, H2 2020
Muscular Dystrophy - Pipeline by Armgo Pharma Inc, H2 2020
Muscular Dystrophy - Pipeline by ARTHEx Biotech SL, H2 2020
Muscular Dystrophy - Pipeline by Asklepios BioPharmaceutical Inc, H2 2020
Muscular Dystrophy - Pipeline by Audentes Therapeutics Inc, H2 2020
Muscular Dystrophy - Pipeline by Avidity Biosciences Inc, H2 2020
Muscular Dystrophy - Pipeline by Benitec Biopharma Inc, H2 2020
Muscular Dystrophy - Pipeline by Biophytis SA, H2 2020
Muscular Dystrophy - Pipeline by Bioprojet SCR, H2 2020
Muscular Dystrophy - Pipeline by CalyGene Biotechnology Inc, H2 2020
Muscular Dystrophy - Pipeline by Casma Therapeutics Inc, H2 2020
Muscular Dystrophy - Pipeline by Catabasis Pharmaceuticals Inc, H2 2020
Muscular Dystrophy - Pipeline by Constant Therapeutics LLC, H2 2020
Muscular Dystrophy - Pipeline by Corcept Therapeutics Inc, H2 2020
Muscular Dystrophy - Pipeline by CRISPR Therapeutics AG, H2 2020
Muscular Dystrophy - Pipeline by Design Therapeutics Inc, H2 2020
Muscular Dystrophy - Pipeline by Dyne Therapeutics Inc, H2 2020
Muscular Dystrophy - Pipeline by Edgewise Therapeutics, H2 2020
Muscular Dystrophy - Pipeline by Elixirgen Therapeutics LLC, H2 2020
Muscular Dystrophy - Pipeline by Enzerna Biosciences LLC, H2 2020
Muscular Dystrophy - Pipeline by Exodos Life Sciences Limited Partnership, H2 2020
Muscular Dystrophy - Pipeline by Expansion Therapeutics Inc, H2 2020
Muscular Dystrophy - Dormant Projects, H2 2020
Muscular Dystrophy - Discontinued Products, H2 2020